This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Cavernous haemangioma

Authoring team

Cavernous haemangiomas are usually not present at birth but appear in the first two weeks of life. Lesions are usually on the face, neck or trunk and are well-circumscribed and lobulated.

The naevus often continues to grow during the first year of life, but after this initial growth period, slow involution occurs. In a majority of cases the lesion regresses completely by 4 or 5 years of age.

Treatment may however be indicated if there is inhibition normal development - for example impairing normal binocular visual development by obstructing the vision from one eye. It may involve systemic or local steroids, sclerosants, interferon, or laser treatment.

Sometimes a naevus shows features of a capillary, as well as a cavernous, haemangioma.

Some cavernous haemangiomata be associated with thrombocytopaenia, in Kasabach-Merritt syndrome.

Notes:

  • strawberry naevus is classified as a subtype of infantile haemangioma

Click here for example image of strawberry naevi


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.